Ausgabe 1/2017
Inhalt (9 Artikel)
Open Access
Review
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection
Csaba Fehér, Alex Soriano, Josep Mensa
Open Access
Review
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease
Paul A. Checchia, Bosco Paes, Louis Bont, Paolo Manzoni, Eric A. F. Simões, Brigitte Fauroux, Josep Figueras-Aloy, Xavier Carbonell-Estrany
Open Access
Review
Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application
Juwon Yim, Leah M. Molloy, Jason G. Newland
Open Access
Review
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection
Alaa Badawi
Open Access
Original Research
Clinical Impact of an Antibiotic Stewardship Program at a Children’s Hospital
Brian R. Lee, Jennifer L. Goldman, Diana Yu, Angela L. Myers, Leslie M. Stach, Erin Hedican, Mary Anne Jackson, Jason G. Newland
Open Access
Original Research
Single-Dose Oritavancin Compared to Standard of Care IV Antibiotics for Acute Bacterial Skin and Skin Structure Infection in the Outpatient Setting: A Retrospective Real-World Study
Patrick J. Anastasio, Pete Wolthoff, Annmarie Galli, Weihong Fan
Open Access
Brief Report
In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients
Aimee M. Dassner, Christina Sutherland, Jennifer Girotto, David P. Nicolau
Open Access
Brief Report
PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease
Alan J. Xiao, Luzelena Caro, Myra W. Popejoy, Jennifer A. Huntington, Ravina Kullar